China 3D Imaging Market Analysis Report 2022 to 2030

China 3D Imaging Market Analysis

$ 3999

China's 3D imaging market is projected to grow from $ 2.44 Bn in 2022 to $ 9.18 Bn by 2030, registering a CAGR of 18% during the forecast period of 2022-30. The market will be driven by rising healthcare spending and rising chronic illness rates, driving up demand for better medical imaging technologies. The market is segmented by product, application, end-user, and portability. Some of the major players include Canon Medical Systems Corporation, GE Healthcare, Mindray Medical International Limited & Fussen Technology.

ID: IN10CNDH001 CATEGORY: Digital Health GEOGRAPHY: China AUTHOR: Vidhi Upadhyay

Buy Now

China 3D Imaging Market Executive Summary

China's 3D imaging market is projected to grow from $ 2.44 Bn in 2022 to $ 9.18 Bn by 2030, registering a CAGR of 18% during the forecast period of 2022-30. China's healthcare industry has been growing rapidly in recent years, driven by factors such as an aging population and increased government spending. Health expenditure (% of GDP) of China was predicted to decrease dramatically from 8.1 percent in 2021 to 2.8% in 2022 due to the widespread outbreak of Omicron and then raise back to 4.3% in 2023 according to the World Health Organization (WHO) Global Health Expenditure database. The four biggest causes of morbidity and death in China, according to the Global Burden of Disease Study (GBD), are ischemic heart disease, stroke, chronic obstructive pulmonary disease, and lung cancer making it a large market space for the 3D Imaging market to aid better diagnostics and treatments for patients.

3D imaging creates a three-dimensional depiction of a patient's interior anatomy, which provides precise anatomical information and can help with the diagnosis and monitoring of a variety of medical conditions. Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI) scans, X-ray Imaging Systems, 3D ultrasound, and Nuclear Imaging system is useful in a range of medical disciplines such as cardiology, neurology, cancer, gynecology, and orthopedics. In China, 3D imaging is becoming increasingly essential, with a developing market for 3D imaging equipment, software, and services.

china 3D imaging market analysis

Market Dynamics

Market Growth Drivers

Several reasons are driving the 3D imaging market in China, including the expanding healthcare industry, rising healthcare spending, and technological advancements. China's rapidly aging population and rising chronic illness rates are driving up demand for better medical imaging technologies. As the Chinese economy expands, the government is increasing its investments in healthcare, including the development and application of 3D imaging technologies. China is also a technological and innovation frontrunner, with numerous local firms producing cutting-edge 3D imaging technologies. These elements are combined to drive the growth of China's 3D imaging industry.

Market Restraints

Recurrent COVID-19 breakouts, the likelihood of further mobility restrictions, and precautionary conduct to halt the virus's transmission caused economic activity to be disrupted for a longer period of time than predicted this may affect the market in the form of regulatory hurdles, high costs, and a shortage of trained healthcare professionals. 3D imaging technology regulation in China is complicated, and certain modern 3D imaging methods may face regulatory restrictions or require extra certifications and permissions. Furthermore, 3D imaging solutions may be costly, and not all patients may be able to afford these operations.

Competitive Landscape

Key Players

Canon Medical Systems Corporation
GE Healthcare
Philips Healthcare
Mindray Medical International Limited (CHN)
Beijing Surewell Medical Equipment Co., Ltd (CHN)
Shenzhen Unicomp Technology Co., Ltd. (CHN)
Fussen Technology Co Ltd (CHN)
SHANGHAI JPS DENTAL CO., LTD (CHN)

Notable Deals

January 2023, Canon Medical Systems Corporation announced a Partnership with ScImage, Inc., as it plans to expand in image exchange solutions and the cardiac market
In November 2022, GE HealthCare announced partnerships with Accuray, Elekta, and RaySearch to combine GE HealthCare's imaging capabilities with precision radiation therapy to give cancer patients early diagnosis and improved treatment alternatives

Healthcare Policies and Regulatory Landscape

The Chinese government and multiple regulatory authorities, especially the National Medical Products Administration (NMPA) and the China Food and Drug Administration (CFDA), determine the legislation and guidelines for 3D imaging in China. These organizations are in charge of overseeing the design, manufacture, and usage of 3D imaging equipment, including 3D imaging systems. All medical products, including 3D imaging systems, must be authorized by the NMPA or the CFDA before they may be marketed and sold in China. This procedure entails a thorough examination of the device's safety and efficacy, as well as an examination of its production and quality control systems.

Reimbursement Scenario

In China, there are 2 types of public health insurance schemes:

The Urban Employees Basic Medical Insurance (UEBMI) for employees
The New Rural Cooperative Medical Scheme (NCMS), URBMI, and URRBMI are for other citizens and/or employees who do not qualify for the UEBMI

The coverage of 3D imaging solutions varies based on the type of scan and the insurance program. Usually, the reimbursement only covers a percentage of the overall cost of the examination, with patients paying for the remainder out of pocket. To make 3D imaging services more accessible to patients, the government is working to improve reimbursement processes and increase the amount covered by the NHSA.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

China 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.